2 completed, 1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Cancer of the Kidney: new trials by email Literature Review of Cancer of the Kidney trials Research Report on Cancer of the Kidney
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland. Renal Cell Cancer, Renal Cell Carcinoma | Completed | Pfizer | 1112 | 2022-05-02 | 2024-10-01 | |
| Non-Interventional Study (NIS) of Nivolumab With or Without Ipilimumab in Participants With Advanced Kidney Cancer Renal Cell Carcinoma, Renal Cell Cancer | Completed | Bristol-Myers Squibb | 623 | 2018-01-21 | 2026-06-16 | |
| MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors MEDI4736 - Non-Small Cell Lung Cancer, Nonsmall Cell Lung Cancer | Phase 2 | Terminated | Washington University School of Medicine | 4 | 2016-09-12 | 2018-11-06 |
Kidney Neoplasms (3) · Carcinoma, Renal Cell (2) · Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1)
Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Kidney Diseases (3) · Male Urogenital Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3) · Urologic Diseases (3) · Urologic Neoplasms (3) · Adenocarcinoma (2) · Carcinoma (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Adnexal Diseases (1)
durvalumab (1)
Bristol-Myers Squibb (1) · Pfizer (1) · Washington University School of Medicine (1)
Finland (1) · France (1) · United States (1)